Patent ID: 8187633
Filing Date: 2012-05-29
Classification: A61K

Abstract:
1. A coated tablet having prolonged gastric retention comprising: a core comprising two or more compressed laminar layers, wherein at least one of the layers comprises a therapeutically active ingredient and rate controlling excipients, wherein the rate controlling excipients is selected from methyl cellulose, hydroxypropyl methylcellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxyethyl methylcellulose, carboxymethylcellulose and sodium carboxymethylcellulose; ethyl cellulose, glycerol palmitostearate, beeswax, glycowax, castor wax, carnauba wax, glycerol monostearate, stearyl alcohol, glycerol behenic acid ester, cetyl alcohol, natural and synthetic glycerides, waxes, fatty acids, hydrophobic polyacrylamide derivatives, hydrophobic methacrylic acid derivatives; vinyl pyrrolidone polymers; alkylene oxide homopolymers; gums of plant, animal, mineral or synthetic origin; and mixtures thereof, wherein at least one of the layers of the core is a swellable compressed layer comprising at least one of (i) a swelling excipient, wherein the swellable excipient is selected from the group consisting of crospovidone; carboxyalkyl celluloses, low substituted hydroxypropyl cellulose, crosslinked carboxyalkylcellulose and their alkali salts; pregelatinized starch, dried starch, sodium starch glycolate; resins; and mixtures thereof, (ii) a gas generating agent selected from the group consisting of calcium carbonate, sodium bicarbonate, potassium bicarbonate, sodium sulfite, sodium bisulfite, sodium metabisulfite, citric acid, malic acid, succinic acid, tartaric acid, fumaric acid, maleic acid, ascorbic acid, glutamic acid, their salts, and mixtures thereof, and (iii) a wicking agent selected from the group consisting of colloidal silicon dioxide, kaolin, titanium dioxide, fumed silicon dioxide, alumina, sodium lauryl sulfate, low molecular weight polyvinylpyrrolidone, bentonite, magnesium aluminum silicate, and mixtures thereof, wherein at least another one of the layers of the core is an inert compressed layer comprising an inert excipient which is insoluble in gastric fluids but soluble in at least one region of the intestine, wherein the inert excipient is selected from a group consisting of cellulose acetate phthalate, hydroxypropyl methylcellulose phthalate, polyvinyl acetate phthalate and polymethacrylate and mixtures thereof, wherein the inert excipient is present in amounts such that a shape and dimensions of the inert compressed layer are maintained at least until the coated tablet is emptied from the stomach, and the inert compressed layer starts eroding in the intestine, and a coating comprising a water insoluble film former adjoining said swellable compressed layer and said inert compressed layer, said water insoluble film former surrounding said core, wherein said coating has a plurality of surfaces including (i) a first surface and (ii) other surfaces forming a cup containing the inert compressed layer, wherein an external surface of the inert compressed layer adjoins the coating and an internal surface of the inert compressed layer adjoins the layer comprising the therapeutically active ingredient and rate controlling excipients, wherein said swellable compressed layer and said coating form a coat rupturing system such that, upon swelling of the swellable compressed layer, the coating ruptures from at least the first surface when the coated tablet is in an aqueous environment, leaving the cup containing the inert compressed layer, so that the active ingredient is released in a controlled manner from an exposed surface of the layer comprising the therapeutically active ingredients and rate controlling excipients, while a shape of the cup is maintained.